Frontage Holdings Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Frontage Holdings's earnings have been declining at an average annual rate of -5.1%, while the Life Sciences industry saw earnings growing at 20.1% annually. Revenues have been growing at an average rate of 22.8% per year. Frontage Holdings's return on equity is 1.7%, and it has net margins of 2.3%.
Belangrijke informatie
-5.1%
Groei van de winst
-8.5%
Groei van de winst per aandeel
| Life Sciences Groei van de industrie | 41.4% |
| Inkomstengroei | 22.8% |
| Rendement op eigen vermogen | 1.7% |
| Nettomarge | 2.3% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Is Frontage Holdings (HKG:1521) A Risky Investment?
Oct 21
What You Can Learn From Frontage Holdings Corporation's (HKG:1521) P/E After Its 26% Share Price Crash
Sep 08What You Can Learn From Frontage Holdings Corporation's (HKG:1521) P/E After Its 26% Share Price Crash
Jun 19Does Frontage Holdings (HKG:1521) Have A Healthy Balance Sheet?
Jun 03Some Investors May Be Willing To Look Past Frontage Holdings' (HKG:1521) Soft Earnings
Apr 04What Is Frontage Holdings Corporation's (HKG:1521) Share Price Doing?
Jan 23With Frontage Holdings Corporation (HKG:1521) It Looks Like You'll Get What You Pay For
Dec 29Analysts Just Shaved Their Frontage Holdings Corporation (HKG:1521) Forecasts Dramatically
Sep 03Does Frontage Holdings (HKG:1521) Have A Healthy Balance Sheet?
Apr 11Should You Investigate Frontage Holdings Corporation (HKG:1521) At HK$2.92?
Dec 29Frontage Holdings (HKG:1521) Seems To Use Debt Quite Sensibly
Oct 10Is It Too Late To Consider Buying Frontage Holdings Corporation (HKG:1521)?
Jun 08Is Now The Time To Look At Buying Frontage Holdings Corporation (HKG:1521)?
Jan 04An Intrinsic Calculation For Frontage Holdings Corporation (HKG:1521) Suggests It's 48% Undervalued
Oct 25Here's Why I Think Frontage Holdings (HKG:1521) Might Deserve Your Attention Today
Sep 15Why Frontage Holdings Corporation (HKG:1521) Could Be Worth Watching
Aug 17Is Frontage Holdings Corporation (HKG:1521) Trading At A 26% Discount?
Jul 12Estimating The Intrinsic Value Of Frontage Holdings Corporation (HKG:1521)
Mar 30Frontage Holdings Corporation's (HKG:1521) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Mar 06Don't Ignore The Fact That This Insider Just Sold Some Shares In Frontage Holdings Corporation (HKG:1521)
Feb 03Frontage Holdings (HKG:1521) Shareholders Booked A 46% Gain In The Last Year
Jan 25How Much Of Frontage Holdings Corporation (HKG:1521) Do Institutions Own?
Jan 04A Look At The Intrinsic Value Of Frontage Holdings Corporation (HKG:1521)
Dec 09
Opbrengsten en kosten
Hoe Frontage Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 260 | 6 | 54 | 6 |
| 31 Mar 24 | 260 | 8 | 53 | 6 |
| 31 Dec 23 | 260 | 11 | 52 | 6 |
| 30 Sep 23 | 260 | 14 | 53 | 6 |
| 30 Jun 23 | 260 | 17 | 54 | 5 |
| 31 Mar 23 | 255 | 22 | 53 | 5 |
| 31 Dec 22 | 250 | 26 | 52 | 4 |
| 30 Sep 22 | 234 | 24 | 50 | 3 |
| 30 Jun 22 | 218 | 23 | 47 | 3 |
| 31 Mar 22 | 201 | 20 | 43 | 3 |
| 31 Dec 21 | 184 | 18 | 39 | 2 |
| 30 Sep 21 | 172 | 20 | 34 | 2 |
| 30 Jun 21 | 160 | 22 | 30 | 2 |
| 31 Mar 21 | 143 | 19 | 27 | 2 |
| 31 Dec 20 | 126 | 17 | 24 | 2 |
| 30 Sep 20 | 114 | 15 | 24 | 2 |
| 30 Jun 20 | 101 | 14 | 24 | 2 |
| 31 Mar 20 | 101 | 16 | 23 | 2 |
| 31 Dec 19 | 100 | 18 | 21 | 2 |
| 30 Sep 19 | 98 | 18 | 18 | 1 |
| 30 Jun 19 | 96 | 18 | 15 | 1 |
| 31 Mar 19 | 89 | 14 | 14 | 1 |
| 31 Dec 18 | 83 | 11 | 14 | 2 |
| 31 Dec 17 | 70 | 10 | 10 | 1 |
| 31 Dec 16 | 49 | 7 | 9 | 0 |
Kwaliteitswinsten: 1521 has a large one-off loss of $3.0M impacting its last 12 months of financial results to 30th June, 2024.
Groeiende winstmarge: 1521's current net profit margins (2.3%) are lower than last year (6.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 1521's earnings have declined by 5.1% per year over the past 5 years.
Versnelling van de groei: 1521's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 1521 had negative earnings growth (-64.9%) over the past year, making it difficult to compare to the Life Sciences industry average (-7%).
Rendement op eigen vermogen
Hoge ROE: 1521's Return on Equity (1.7%) is considered low.